JUAN
PASQUAU LIAÑO
Investigador en el periodo 2022-2023
Hospital Universitario de Valme
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Valme (16)
2019
-
Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: A preliminary
BMC Infectious Diseases, Vol. 19, Núm. 1
2018
2015
-
Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes
Antiviral Research, Vol. 120, pp. 79-84
2014
-
Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting
HIV Medicine, Vol. 15, Núm. 7, pp. 417-424
2013
-
Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of staphylococcus aureus bacteremia
Clinical Infectious Diseases, Vol. 57, Núm. 9, pp. 1225-1233
2011
-
Liver toxicity of antiretroviral combinations including fosamprenavir plus ritonavir 1400/100mg once daily in HIV/Hepatitis C Virus-Coinfected Patients
AIDS Patient Care and STDs, Vol. 25, Núm. 7, pp. 395-402
2010
2009
-
Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: Effect of hepatitis virus co-infection and pre-existing fibrosis
Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 1, pp. 178-183
2008
-
Liver toxicity of antiretroviral combinations including atazanavir/ ritonavir in patients co-infected with HIV and hepatitis viruses: Impact of pre-existing liver fibrosis
Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 4, pp. 925-932
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313
2007
-
Ensayo clínico aleatorizado para evaluar tres pautas cortas de tratamiento de la infección latente tuberculosa en pacientes infectados por el VIH
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 5, pp. 305-310
2005
-
Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: The VESD study
HIV Clinical Trials, Vol. 6, Núm. 6, pp. 320-328
2003
-
Ensayo clínico aleatorizado de tres pautas de quimioprofilaxis para prevenir la tuberculosis en pacientes infectados por el vih con anergia cutánea
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 21, Núm. 6, pp. 287-292
2000
-
Prevalence of primary mutations in human immunodeficiency virus with resistance to nucleoside analogues in naive human immunodeficiency virus-infected patients from Andalucía (Spain)
Medicina Clinica, Vol. 115, Núm. 11, pp. 423-425
1998
-
Comparative study of bacteremias caused by Enterococcus spp. with and without High-level resistance to gentamicin
Journal of Clinical Microbiology, Vol. 36, Núm. 2, pp. 520-525
1996
-
Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 15, Núm. 9, pp. 705-711